Strategic Analysis for Market Access

Our strategic market access analyses include:

  • The technology's positioning withinthe medical and competitivelandscape;
  • Monitoring of regulatory and scientific developments in the relevant therapeutic area;
  • Identification of missing data by clinical development stage;
  • A assessment of the technology's suitability healthcare with various funding models:
    • under general law (LPPR, LATM, intra-GHS, NABM, and CCAM, technical flat rate);
    • funding for innovation (RIHN, Innovation Grant, PECAN, PECT, ministerial research programs, Article 51, and BPI funding);
  • Market analysis based on open data, as well as the organization and management of expert panels or surveys of industry practices;
  • And organizing and providing support for strategic meetings with health authorities (Ministry of Health, High Authority for Health, etc.);
  • An analysis of the needs for the production of health economics data.

 

 

 

Strategy Workshops

We also offer strategic workshops that provide opportunities for discussion and group brainstorming to identify the key elements of your strategy.

 

 

Ongoing consulting contracts based on time spent

And, to provide ongoing support for these strategic issues over the medium and long term, we also offer ongoing contracts based on time spent.

More activities Market access

Preparation and submission of funding applications

Price negotiation

Support for clinical trial design

Critical review of documents

For all health products

Medical device (MD)

  • Single-use, implantable, equipment, etc.
  • Therapeutic, Diagnostic, or Prognostic

In vitro diagnosis

  • Proceedings of Associated Biology
  • Companion Test
  • Equipment and supplies

And other technologies

  • Connected medical devices or remote monitoring activities
  • Foods for special medical purposes,
  • …